Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.6266683194169958e-07,7.308975642308976,114.25070374378934,"['RPL3', 'RPS7', 'RPL23A', 'RPL10A', 'RPS26', 'RPS25', 'RPS15A', 'RPS27', 'RPL26', 'RPL15', 'FAU', 'RPS27A', 'RPL17']",4.408271145620059e-05,0,0,13
2,Complement and Coagulation Cascades WP558,2.9777576243470522e-05,12.266465256797582,127.8380946748419,"['C3', 'CPB2', 'C6', 'SERPIND1', 'MASP2', 'F5']",0.004034861580990256,0,0,6
3,Complement Activation WP545,0.0014960343206268558,17.382805816937555,113.07406468543246,"['C3', 'C6', 'MASP2']",0.11336744915721235,0,0,3
4,Development and heterogeneity of the ILC family WP3893,0.002020254730593744,15.208832335329342,94.3636819075127,"['IL5', 'IL7', 'IL18']",0.11336744915721235,0,0,3
5,Sleep regulation WP3591,0.0020916503534541024,8.556978030662242,52.79485915617185,"['IL18', 'CRH', 'FOS', 'HCRTR2']",0.11336744915721235,0,0,4
6,Spinal Cord Injury WP2431,0.003019612732073851,3.971969696969697,23.047857376424012,"['EGR1', 'NR4A1', 'CCND1', 'FOS', 'LTB', 'PDYN', 'TNFSF13B']",0.13197230164641102,0,0,7
7,Cells and molecules involved in local acute inflammatory response  WP4493,0.0034088786403131998,40.45373134328358,229.83269194767604,"['C3', 'C6']",0.13197230164641102,0,0,2
8,Allograft Rejection WP2328,0.013119756797444046,4.776541247129482,20.699791258892002,"['C3', 'CASP8', 'C6', 'IL5']",0.39708865680061,0,0,4
9,Unfolded protein response WP4925,0.013612074476936202,6.754491017964072,29.02268384108556,"['XBP1', 'CASP8', 'DDIT3']",0.39708865680061,0,0,3
10,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.014916233611804166,13.480597014925372,56.69002411882699,"['CCND1', 'FN1']",0.39708865680061,0,0,2
11,Complement system WP2806,0.017012022834448536,4.388280172063956,17.877129176316323,"['C3', 'FKBP2', 'C6', 'MASP2']",0.39708865680061,0,0,4
12,Cytokines and Inflammatory Response WP530,0.018873363764017718,11.553944562899787,45.869202382433905,"['IL5', 'IL7']",0.39708865680061,0,0,2
13,"GPCRs, Class A Rhodopsin-like WP455",0.01904853335205878,3.015105740181269,11.94212579887302,"['LPAR6', 'P2RY14', 'ACKR4', 'GPR3', 'MCHR1', 'HCRTR2']",0.39708865680061,0,0,6
14,Prader-Willi and Angelman Syndrome WP3998,0.023220855816026776,3.95898337361752,14.896484343700013,"['GABRR2', 'MAGEL2', 'CCND1', 'TYR']",0.42240611651267707,0,0,4
15,Oxidation by Cytochrome P450 WP43,0.026913252433507798,5.063622754491018,18.30568723017206,"['CYP39A1', 'CYP26A1', 'CYP2C18']",0.42240611651267707,0,0,3
16,Serotonin and anxiety-related events WP3944,0.027928263994890016,8.985074626865671,32.14963979149234,"['CRH', 'FOS']",0.42240611651267707,0,0,2
17,Inflammatory Response Pathway WP453,0.027928263994890016,8.985074626865671,32.14963979149234,"['IL5', 'FN1']",0.42240611651267707,0,0,2
18,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.029615188980593593,4.8607185628742515,17.107142991990912,"['CASP8', 'IL18', 'NLRC4']",0.42240611651267707,0,0,3
19,Peptide GPCRs WP24,0.029615188980593593,4.8607185628742515,17.107142991990912,"['GNRHR', 'TAC4', 'HCRTR2']",0.42240611651267707,0,0,3
20,Serotonin and anxiety WP3947,0.044058830464547144,6.737313432835821,21.03543863024854,"['CRH', 'FOS']",0.5685687169472513,0,0,2
21,Hypertrophy Model WP516,0.044058830464547144,6.737313432835821,21.03543863024854,"['NR4A3', 'IL18']",0.5685687169472513,0,0,2
22,COVID-19 adverse outcome pathway WP4891,0.04793354078547961,40.336309523809526,122.53927986330825,['IL7'],0.5904540705847715,0,0,1
23,Small cell lung cancer WP4658,0.06026895595955868,2.4742873934763443,6.950120214899432,"['CASP8', 'CCND1', 'LAMB4', 'FN1', 'CYCS']",0.6178376162673659,0,0,5
24,Vitamin D Receptor Pathway WP2877,0.06026895595955868,2.4742873934763443,6.950120214899432,"['CEACAM1', 'CCND1', 'IGFBP5', 'PNOC', 'LGALS9']",0.6178376162673659,0,0,5
25,Apoptosis Modulation by HSP70 WP384,0.06280185138270857,5.388656716417911,14.914566308533633,"['CASP8', 'CYCS']",0.6178376162673659,0,0,2
26,Nanomaterial induced apoptosis WP2507,0.06280185138270857,5.388656716417911,14.914566308533633,"['CASP8', 'CYCS']",0.6178376162673659,0,0,2
27,TGF-beta Receptor Signaling WP560,0.06813850687373688,3.372754491017964,9.059936216274105,"['FST', 'FOS', 'TGFBR2']",0.6178376162673659,0,0,3
28,Purinergic signaling WP4900,0.06955074304373524,5.0514925373134325,13.465756973990983,"['LPAR6', 'P2RY14']",0.6178376162673659,0,0,2
29,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.07103424711748615,20.166666666666668,53.33262881678331,['IL5'],0.6178376162673659,0,0,1
30,let-7 inhibition of ES cell reprogramming WP3299,0.07103424711748615,20.166666666666668,53.33262881678331,['EGR1'],0.6178376162673659,0,0,1
31,IL-18 signaling pathway WP4754,0.07784747570241098,1.859001302648719,4.746037401715453,"['NR4A1', 'CASP8', 'FN1', 'IL18', 'CYCS', 'FOS', 'LTB', 'NFKBIE']",0.6178376162673659,0,0,8
32,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.07949508291086108,2.5722865722865724,6.513184219664243,"['CCND1', 'CYCS', 'FOS', 'TGFBR2']",0.6178376162673659,0,0,4
33,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.08584930194889183,3.0345808383233535,7.450387022230799,"['FST', 'FOS', 'TGFBR2']",0.6178376162673659,0,0,3
34,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.0905536497483511,2.9603475974879507,7.110200719599149,"['IL5', 'PTPN6', 'FOS']",0.6178376162673659,0,0,3
35,Cytosolic DNA-sensing pathway WP4655,0.0905536497483511,2.9603475974879507,7.110200719599149,"['CASP8', 'IL18', 'POLR2K']",0.6178376162673659,0,0,3
36,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.09108548069440724,4.252945797329144,10.189874679952013,"['ANGPT2', 'TGFBR2']",0.6178376162673659,0,0,2
37,IL-7 signaling pathway WP205,0.09108548069440724,4.252945797329144,10.189874679952013,"['CCND1', 'IL7']",0.6178376162673659,0,0,2
38,Nonalcoholic fatty liver disease WP4396,0.09143855605380238,1.995740676539052,4.773987424860344,"['XBP1', 'CASP8', 'DDIT3', 'LEPR', 'CYCS', 'COX7A1']",0.6178376162673659,0,0,6
39,Nucleotide GPCRs WP80,0.0935760744030423,13.443452380952381,31.84727712829279,['LPAR6'],0.6178376162673659,0,0,1
40,7-oxo-C and 7beta-HC pathways WP5064,0.09864570861020507,4.04,9.357531016438434,"['HSD11B1', 'ACOT6']",0.6178376162673659,0,0,2
41,16p11.2 distal deletion syndrome WP4950,0.10637463797262563,3.8473347547974415,8.621061917595553,"['C3', 'PLN']",0.6178376162673659,0,0,2
42,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.10637463797262563,3.8473347547974415,8.621061917595553,"['CCND1', 'FGF1']",0.6178376162673659,0,0,2
43,Corticotropin-releasing hormone signaling pathway WP2355,0.10895717482764128,2.2810979994078586,5.056738878702301,"['NR4A1', 'IL18', 'CRH', 'FOS']",0.6178376162673659,0,0,4
44,Phosphodiesterases in neuronal function WP4222,0.11039367289877208,2.6964071856287424,5.9420791413394625,"['ADCY10', 'PDE6C', 'PDE5A']",0.6178376162673659,0,0,3
45,Photodynamic therapy-induced unfolded protein response WP3613,0.11425969390265846,3.6721845318860242,7.9660016194413625,"['XBP1', 'DDIT3']",0.6178376162673659,0,0,2
46,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.11557250065050428,10.081845238095237,21.755182686036832,['CYP2C18'],0.6178376162673659,0,0,1
47,Hematopoietic Stem Cell Differentiation WP2849,0.12228880912131691,3.5122647631408177,7.380566906114314,"['IL5', 'FOS']",0.6178376162673659,0,0,2
48,Tryptophan metabolism WP465,0.13045040682747497,3.3656716417910446,6.855072605146387,"['CYP2C18', 'ACMSD']",0.6178376162673659,0,0,2
49,White fat cell differentiation WP4149,0.13045040682747497,3.3656716417910446,6.855072605146387,"['DDIT3', 'EBF1']",0.6178376162673659,0,0,2
50,Oxysterols derived from cholesterol WP4545,0.13045040682747497,3.3656716417910446,6.855072605146387,"['CYP39A1', 'ACOT6']",0.6178376162673659,0,0,2
51,Pre-implantation embryo WP3527,0.13045040682747497,3.3656716417910446,6.855072605146387,"['EGR1', 'DDIT3']",0.6178376162673659,0,0,2
52,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.1370366817685184,8.064880952380953,16.029004434452634,['HSD11B1'],0.6178376162673659,0,0,1
53,Drug Induction of Bile Acid Pathway WP2289,0.1370366817685184,8.064880952380953,16.029004434452634,['SLC10A1'],0.6178376162673659,0,0,1
54,DNA damage response WP707,0.14289695459214247,2.378126100739697,4.6269570662098145,"['CASP8', 'CCND1', 'CYCS']",0.6178376162673659,0,0,3
55,Oncostatin M Signaling Pathway WP2374,0.14289695459214247,2.378126100739697,4.6269570662098145,"['EGR1', 'PRKCH', 'FOS']",0.6178376162673659,0,0,3
56,TGF-beta Signaling Pathway WP366,0.1438747446509808,1.8576599977893224,3.6016538425321625,"['CCND1', 'CITED1', 'FN1', 'FOS', 'TGFBR2']",0.6178376162673659,0,0,5
57,TYROBP causal network in microglia WP3945,0.14712709609788488,3.1063145809414467,5.953122878098411,"['C3', 'IL18']",0.6178376162673659,0,0,2
58,Differentiation Pathway WP2848,0.14712709609788488,3.1063145809414467,5.953122878098411,"['FST', 'FGF1']",0.6178376162673659,0,0,2
59,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.14763727245450867,1.8406352683461118,3.521129516894504,"['EGR1', 'CAV3', 'SST', 'KCNQ1', 'TAC1']",0.6178376162673659,0,0,5
60,Hepatitis B infection WP4666,0.15144144287096434,1.8239172907847607,3.442746471585418,"['CASP8', 'SLC10A1', 'CYCS', 'FOS', 'TGFBR2']",0.6178376162673659,0,0,5
61,miRNA regulation of DNA damage response WP1530,0.1543663801139578,2.2880465484126087,4.275046599455657,"['CASP8', 'CCND1', 'CYCS']",0.6178376162673659,0,0,3
62,Lung fibrosis WP3624,0.15562133986414645,2.991044776119403,5.564328925513294,"['IL5', 'FGF1']",0.6178376162673659,0,0,2
63,Glucuronidation WP698,0.15798145797652496,6.720238095238095,12.400704873678485,['PGM5'],0.6178376162673659,0,0,1
64,LDLRAD4 and what we know about it WP4904,0.15798145797652496,6.720238095238095,12.400704873678485,['TGFBR2'],0.6178376162673659,0,0,1
65,Acute viral myocarditis WP4298,0.1602064937337551,2.245508982035928,4.112181983538313,"['CASP8', 'CCND1', 'CYCS']",0.6178376162673659,0,0,3
66,Circadian rhythm related genes WP3594,0.16131569073168586,1.6762996145431817,3.0582276430567794,"['PER2', 'EGR1', 'MAGEL2', 'CRH', 'RPS27A', 'HCRTR2']",0.6178376162673659,0,0,6
67,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.16611284775692778,2.204518236254763,3.957304046115092,"['ANGPT2', 'FN1', 'ANGPTL1']",0.6178376162673659,0,0,3
68,Vitamin A and carotenoid metabolism WP716,0.17287273326118638,2.784354091610911,4.887097190898995,"['CYP26A1', 'RBP2']",0.6178376162673659,0,0,2
69,Selective expression of chemokine receptors during T-cell polarization WP4494,0.1784193611138764,5.759778911564626,9.927661708492094,['IL5'],0.6178376162673659,0,0,1
70,Bile acids synthesis and enterohepatic circulation  WP4389,0.1784193611138764,5.759778911564626,9.927661708492094,['SLC10A1'],0.6178376162673659,0,0,1
71,Blood Clotting Cascade WP272,0.1784193611138764,5.759778911564626,9.927661708492094,['F5'],0.6178376162673659,0,0,1
72,Canonical NF-KB pathway WP4562,0.1784193611138764,5.759778911564626,9.927661708492094,['NFKBIE'],0.6178376162673659,0,0,1
73,Leptin and adiponectin WP3934,0.1784193611138764,5.759778911564626,9.927661708492094,['LEPR'],0.6178376162673659,0,0,1
74,Mitochondrial CII Assembly WP4920,0.1784193611138764,5.759778911564626,9.927661708492094,['SDHAF1'],0.6178376162673659,0,0,1
75,Endometrial cancer WP4155,0.18419942617619461,2.090026842865992,3.5357742161594787,"['CCND1', 'FOS', 'FGF1']",0.6178376162673659,0,0,3
76,Myometrial relaxation and contraction pathways WP289,0.18742684226118828,1.6859939759036144,2.8229721432114707,"['PRKCH', 'IGFBP5', 'MAFF', 'CRH', 'FOS']",0.6178376162673659,0,0,5
77,Oxidative Damage WP3941,0.19041422614417308,2.60433317284545,4.319425748646743,"['CYCS', 'NFKBIE']",0.6178376162673659,0,0,2
78,Apoptosis WP254,0.1965338539104292,2.020059880239521,3.286476987914805,"['CASP8', 'CYCS', 'NFKBIE']",0.6178376162673659,0,0,3
79,EDA signaling in hair follicle development WP3930,0.19836262170582128,5.039434523809524,8.152084095359237,['LTB'],0.6178376162673659,0,0,1
80,Farnesoid X receptor pathway WP2879,0.19836262170582128,5.039434523809524,8.152084095359237,['SLC10A1'],0.6178376162673659,0,0,1
81,Fas ligand pathway and stress induction of heat shock proteins WP314,0.19927253723652463,2.522761194029851,4.069420312546154,"['CASP8', 'CYCS']",0.6178376162673659,0,0,2
82,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.19927253723652463,2.522761194029851,4.069420312546154,"['DDIT3', 'FOS']",0.6178376162673659,0,0,2
83,VEGFA-VEGFR2 Signaling Pathway WP3888,0.20648246065521333,1.3341875658587987,2.1047339944565238,"['DUSP5', 'NR4A1', 'EGR1', 'NR4A3', 'CCND1', 'FN1', 'CYCS', 'PTPN6', 'MYH11', 'RPL26', 'RPL10A', 'APOLD1']",0.6178376162673659,0,0,12
84,Head and Neck Squamous Cell Carcinoma WP4674,0.21539264236340508,1.9234388366124893,2.95304155254361,"['CASP8', 'CCND1', 'TGFBR2']",0.6178376162673659,0,0,3
85,Hedgehog Signaling Pathway WP4249,0.2171250261517565,2.3740122914837576,3.625786083818327,"['EVC', 'CCND1']",0.6178376162673659,0,0,2
86,NO/cGMP/PKG mediated Neuroprotection WP4008,0.2171250261517565,2.3740122914837576,3.625786083818327,"['CNGB3', 'CYCS']",0.6178376162673659,0,0,2
87,Cancer immunotherapy by CTLA4 blockade WP4582,0.21782317614392305,4.479166666666667,6.826570994702549,['PTPN6'],0.6178376162673659,0,0,1
88,Transcriptional cascade regulating adipogenesis WP4211,0.21782317614392305,4.479166666666667,6.826570994702549,['DDIT3'],0.6178376162673659,0,0,1
89,Dopamine metabolism WP2436,0.21782317614392305,4.479166666666667,6.826570994702549,['TYR'],0.6178376162673659,0,0,1
90,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.21782317614392305,4.479166666666667,6.826570994702549,['MAFF'],0.6178376162673659,0,0,1
91,miR-509-3p alteration of YAP1/ECM axis WP3967,0.21782317614392305,4.479166666666667,6.826570994702549,['FN1'],0.6178376162673659,0,0,1
92,Nanoparticle triggered regulated necrosis WP2513,0.21782317614392305,4.479166666666667,6.826570994702549,['CASP8'],0.6178376162673659,0,0,1
93,Neuroinflammation WP4919,0.21782317614392305,4.479166666666667,6.826570994702549,['FOS'],0.6178376162673659,0,0,1
94,Gastrin signaling pathway WP4659,0.2196176966063627,1.7017859965228386,2.5796812109903264,"['EGR1', 'PRKCH', 'CCND1', 'FOS']",0.6178376162673659,0,0,4
95,Integrated breast cancer pathway WP1984,0.22172470671446037,1.5796780873493976,2.3794986847609145,"['PLK3', 'CASP8', 'CCND1', 'FAU', 'TGFBR2']",0.6178376162673659,0,0,5
96,Metapathway biotransformation Phase I and II WP702,0.22477049748899086,1.6839339339339339,2.5135667727271667,"['CYP39A1', 'CYP26A1', 'GLYAT', 'CYP2C18']",0.6178376162673659,0,0,4
97,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.2261045299342263,2.3060127931769725,3.428482656601984,"['CASP8', 'CXCL17']",0.6178376162673659,0,0,2
98,Apoptosis Modulation and Signaling WP1772,0.2281704012664781,1.8639797328420082,2.7543330548663145,"['CASP8', 'CYCS', 'FOS']",0.6178376162673659,0,0,3
99,Cancer immunotherapy by PD-1 blockade WP4585,0.23681267372470682,4.030952380952381,5.806529893420511,['PDCD1LG2'],0.6178376162673659,0,0,1
100,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.23681267372470682,4.030952380952381,5.806529893420511,['CCND1'],0.6178376162673659,0,0,1
101,Leptin Insulin Overlap WP3935,0.23681267372470682,4.030952380952381,5.806529893420511,['LEPR'],0.6178376162673659,0,0,1
102,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.23681267372470682,4.030952380952381,5.806529893420511,['CCND1'],0.6178376162673659,0,0,1
103,MAPK Signaling Pathway WP382,0.23812027092792037,1.4163333333333334,2.032409146837127,"['DUSP4', 'NR4A1', 'DUSP1', 'DDIT3', 'FOS', 'FGF1', 'TGFBR2']",0.6178376162673659,0,0,7
104,Non-small cell lung cancer WP4255,0.24759037331535763,1.781349066572737,2.486726991106986,"['CASP8', 'CCND1', 'CYCS']",0.6178376162673659,0,0,3
105,IL-3 signaling pathway WP286,0.2531748036563929,2.1234878240377064,2.916982360265642,"['PTPN6', 'FOS']",0.6178376162673659,0,0,2
106,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.25534248347581173,3.664231601731602,5.0022241679461565,['SST'],0.6178376162673659,0,0,1
107,Dopaminergic Neurogenesis WP2855,0.25534248347581173,3.664231601731602,5.0022241679461565,['SLC18A2'],0.6178376162673659,0,0,1
108,Galanin receptor pathway WP4970,0.25534248347581173,3.664231601731602,5.0022241679461565,['FOS'],0.6178376162673659,0,0,1
109,Genes targeted by miRNAs in adipocytes WP1992,0.25534248347581173,3.664231601731602,5.0022241679461565,['KCNQ1'],0.6178376162673659,0,0,1
110,IL1 and megakaryocytes in obesity WP2865,0.25534248347581173,3.664231601731602,5.0022241679461565,['IL18'],0.6178376162673659,0,0,1
111,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.25534248347581173,3.664231601731602,5.0022241679461565,['TGFBR2'],0.6178376162673659,0,0,1
112,Overview of nanoparticle effects WP3287,0.25534248347581173,3.664231601731602,5.0022241679461565,['FN1'],0.6178376162673659,0,0,1
113,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.27126977118679624,2.017014925373134,2.6314813527821617,"['CCND1', 'FOS']",0.6333147259148387,0,0,2
114,Cori Cycle WP1946,0.27342370085622186,3.3586309523809526,4.355246479549699,['PGAM1'],0.6333147259148387,0,0,1
115,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.27342370085622186,3.3586309523809526,4.355246479549699,['CCND1'],0.6333147259148387,0,0,1
116,Major receptors targeted by epinephrine and norepinephrine WP4589,0.27342370085622186,3.3586309523809526,4.355246479549699,['ADCY10'],0.6333147259148387,0,0,1
117,miRNAs involved in DNA damage response WP1545,0.27342370085622186,3.3586309523809526,4.355246479549699,['CCND1'],0.6333147259148387,0,0,1
118,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2803146722816186,1.9676738259919913,2.502571153288148,"['XBP1', 'DDIT3']",0.6437735270196495,0,0,2
119,IL-4 signaling pathway WP395,0.2893509113958364,1.920682302771855,2.3818671282040573,"['PTPN6', 'FOS']",0.6518942051840378,0,0,2
120,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.2910671543441645,3.1000457875457874,3.826080440272297,['FN1'],0.6518942051840378,0,0,1
121,Mammalian disorder of sexual development WP4842,0.2910671543441645,3.1000457875457874,3.826080440272297,['FST'],0.6518942051840378,0,0,1
122,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2995395874118811,1.468086268086268,1.7697907565263185,"['CLDN5', 'CLDN20', 'FN1', 'TGFBR2']",0.6522870455999953,0,0,4
123,Exercise-induced Circadian Regulation WP410,0.3073780834532366,1.8331071913161465,2.1624739282221963,"['PER2', 'CLDN5']",0.6522870455999953,0,0,2
124,Canonical and non-canonical TGF-B signaling WP3874,0.30828341169742646,2.878401360544218,3.3871177874125067,['TGFBR2'],0.6522870455999953,0,0,1
125,Cholesterol Biosynthesis Pathway WP197,0.30828341169742646,2.878401360544218,3.3871177874125067,['MSMO1'],0.6522870455999953,0,0,1
126,MAPK pathway in congenital thyroid cancer WP4928,0.30828341169742646,2.878401360544218,3.3871177874125067,['FOS'],0.6522870455999953,0,0,1
127,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.30828341169742646,2.878401360544218,3.3871177874125067,['CCND1'],0.6522870455999953,0,0,1
128,PPAR-alpha pathway WP2878,0.30828341169742646,2.878401360544218,3.3871177874125067,['CCND1'],0.6522870455999953,0,0,1
129,Breast cancer pathway WP4262,0.31049826155866933,1.4416559416559416,1.6861275973507306,"['SHC4', 'CCND1', 'FOS', 'FGF1']",0.6522870455999953,0,0,4
130,Genotoxicity pathway WP4286,0.31635995003743717,1.7922388059701493,2.0626421749514563,"['PLK3', 'RPS27']",0.6530397501831304,0,0,2
131,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3250827865306811,2.686309523809524,3.0185399321915507,['FN1'],0.6530397501831304,0,0,1
132,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3250827865306811,2.686309523809524,3.0185399321915507,['NFKBIE'],0.6530397501831304,0,0,1
133,Kynurenine Pathway and links to Cellular Senescence WP5044,0.3250827865306811,2.686309523809524,3.0185399321915507,['ACMSD'],0.6530397501831304,0,0,1
134,miRNA targets in ECM and membrane receptors WP2911,0.3250827865306811,2.686309523809524,3.0185399321915507,['FN1'],0.6530397501831304,0,0,1
135,Synaptic Vesicle Pathway WP2267,0.32531500470377345,1.7531473069435433,1.9687166154059297,"['SLC32A1', 'SLC18A2']",0.6530397501831304,0,0,2
136,Imatinib and Chronic Myeloid Leukemia WP3640,0.3414753440058429,2.5182291666666665,2.7057863755902973,['SPRED2'],0.6626473673937124,0,0,1
137,Nicotine Activity on Dopaminergic Neurons WP1602,0.3414753440058429,2.5182291666666665,2.7057863755902973,['SLC18A2'],0.6626473673937124,0,0,1
138,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.3414753440058429,2.5182291666666665,2.7057863755902973,['CYP26A1'],0.6626473673937124,0,0,1
139,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.3414753440058429,2.5182291666666665,2.7057863755902973,['BCL2L14'],0.6626473673937124,0,0,1
140,Kit receptor signaling pathway WP304,0.3431289747159632,1.6798507462686567,1.7968504742081397,"['PTPN6', 'FOS']",0.6626473673937124,0,0,2
141,PI3K-Akt signaling pathway WP4172,0.34477224650373967,1.2397926634768741,1.3202195447138256,"['ANGPT2', 'CCND1', 'LPAR6', 'IL7', 'LAMB4', 'FN1', 'FGF1']",0.6626473673937124,0,0,7
142,G1 to S cell cycle control WP45,0.3519805497574602,1.6454462381967712,1.718141002023485,"['CCND1', 'RPA3']",0.6702444460762076,0,0,2
143,Regulation of toll-like receptor signaling pathway WP1449,0.3536714235752682,1.440333618477331,1.4970640082693958,"['CASP8', 'PTPN6', 'FOS']",0.6702444460762076,0,0,3
144,Vitamin D in inflammatory diseases WP4482,0.3574709070198535,2.369922969187675,2.4379428372294605,['DUSP1'],0.6727403875165299,0,0,1
145,22q11.2 copy number variation syndrome WP4657,0.36031638877771166,1.4232828460725608,1.4528483815132793,"['CLDN5', 'CYP26A1', 'SERPIND1']",0.6734189059224818,0,0,3
146,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3730790621438195,2.238095238095238,2.2066833900247085,['EGR1'],0.6740295056065005,0,0,1
147,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3730790621438195,2.238095238095238,2.2066833900247085,['CASP8'],0.6740295056065005,0,0,1
148,NAD+ biosynthetic pathways WP3645,0.3730790621438195,2.238095238095238,2.2066833900247085,['ACMSD'],0.6740295056065005,0,0,1
149,Ovarian infertility WP34,0.3730790621438195,2.238095238095238,2.2066833900247085,['EGR1'],0.6740295056065005,0,0,1
150,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.3730790621438195,2.238095238095238,2.2066833900247085,['FOS'],0.6740295056065005,0,0,1
151,AGE/RAGE pathway WP2324,0.3869407338791158,1.5208110391439031,1.4439853534485712,"['CASP8', 'CYCS']",0.6833232706825968,0,0,2
152,Nuclear Receptors Meta-Pathway WP2882,0.3879104032348273,1.2042205888984083,1.140373879639735,"['EGR1', 'CCND1', 'SLC10A1', 'B3GNT5', 'MAFF', 'TGFBR2']",0.6833232706825968,0,0,6
153,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.3883091648897413,2.1201441102756893,2.0055576142470066,['PTPN6'],0.6833232706825968,0,0,1
154,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3883091648897413,2.1201441102756893,2.0055576142470066,['CASP8'],0.6833232706825968,0,0,1
155,NRF2 pathway WP2884,0.3999174384181294,1.3288477989076792,1.2178852299614116,"['EGR1', 'MAFF', 'TGFBR2']",0.694410923706741,0,0,3
156,Gastric Cancer Network 1 WP2361,0.4031703456835714,2.013988095238095,1.8294989560163462,['GATD3A'],0.694410923706741,0,0,1
157,Microglia Pathogen Phagocytosis Pathway WP3937,0.4031703456835714,2.013988095238095,1.8294989560163462,['PTPN6'],0.694410923706741,0,0,1
158,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.40970985886645966,1.2403788403788403,1.1067975201133455,"['SHC4', 'EGR1', 'LINGO1', 'FOS']",0.694410923706741,0,0,4
159,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.41767151499704347,1.9179421768707483,1.6744786059304109,['CCND1'],0.694410923706741,0,0,1
160,Estrogen signaling pathway WP712,0.41767151499704347,1.9179421768707483,1.6744786059304109,['FOS'],0.694410923706741,0,0,1
161,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.41767151499704347,1.9179421768707483,1.6744786059304109,['CCND1'],0.694410923706741,0,0,1
162,MTHFR deficiency WP4288,0.41767151499704347,1.9179421768707483,1.6744786059304109,['CYCS'],0.694410923706741,0,0,1
163,Physiological and pathological hypertrophy of the heart WP1528,0.41767151499704347,1.9179421768707483,1.6744786059304109,['FOS'],0.694410923706741,0,0,1
164,Adipogenesis WP236,0.4259468136208453,1.272518121651434,1.0860188725108835,"['CYP26A1', 'DDIT3', 'EBF1']",0.7038511371417626,0,0,3
165,DNA Mismatch Repair WP531,0.4318213687496293,1.8306277056277056,1.5372573039449045,['RPA3'],0.7092338844312093,0,0,1
166,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.43774248043018144,1.365545155578042,1.1281102894011992,"['EGR1', 'FOS']",0.714627784316742,0,0,2
167,Oxidative Stress WP408,0.4456283934740067,1.7509057971014492,1.4152044058267925,['FOS'],0.7194230484860262,0,0,1
168,Toll-like Receptor Signaling Pathway WP75,0.44598919610941845,1.342686567164179,1.0841664356453171,"['CASP8', 'FOS']",0.7194230484860262,0,0,2
169,Melanoma WP4685,0.45416805670912125,1.3205774406655248,1.0423159012018806,"['CCND1', 'FOS']",0.7282813217051589,0,0,2
170,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4591008712108314,1.677827380952381,1.3061640024769343,['TGFBR2'],0.7318608005772665,0,0,1
171,Endothelin Pathways WP2197,0.472246884539187,1.6105952380952382,1.2083545045725517,['ADCY10'],0.7346434493273734,0,0,1
172,Nanoparticle-mediated activation of receptor signaling WP2643,0.472246884539187,1.6105952380952382,1.2083545045725517,['FN1'],0.7346434493273734,0,0,1
173,MECP2 and Associated Rett Syndrome WP3584,0.4782824154804625,1.2583955223880596,0.9281345172204147,"['GABRR2', 'SST']",0.7346434493273734,0,0,2
174,Insulin Signaling WP481,0.47970359580211114,1.1265251265251266,0.8275305718106152,"['EGR1', 'XBP1', 'PRKCH', 'FOS']",0.7346434493273734,0,0,4
175,IL17 signaling pathway WP2112,0.4850743213145209,1.5485347985347986,1.1202923933094495,['IL17RE'],0.7346434493273734,0,0,1
176,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4850743213145209,1.5485347985347986,1.1202923933094495,['CASP8'],0.7346434493273734,0,0,1
177,Prolactin Signaling Pathway WP2037,0.48617532193829155,1.23894374282434,0.8935088516411682,"['PTPN6', 'FOS']",0.7346434493273734,0,0,2
178,Endoderm differentiation WP2853,0.49523161076338396,1.1395322562422325,0.8007831894140403,"['DUSP4', 'DUSP5', 'TRIM5']",0.7346434493273734,0,0,3
179,The influence of laminopathies on Wnt signaling WP4844,0.4975908794745722,1.4910714285714286,1.04073366203699,['CCND1'],0.7346434493273734,0,0,1
180,GABA receptor Signaling WP4159,0.4975908794745722,1.4910714285714286,1.04073366203699,['SLC32A1'],0.7346434493273734,0,0,1
181,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.4975908794745722,1.4910714285714286,1.04073366203699,['FOS'],0.7346434493273734,0,0,1
182,Neural Crest Cell Migration during Development WP4564,0.4975908794745722,1.4910714285714286,1.04073366203699,['FOS'],0.7346434493273734,0,0,1
183,Leptin signaling pathway WP2034,0.5017363629834802,1.2017821341055914,0.8288456677868742,"['CCND1', 'LEPR']",0.7346434493273734,0,0,2
184,Glycolysis and Gluconeogenesis WP534,0.5098040713272052,1.4377125850340136,0.9686283760194752,['PGAM1'],0.7346434493273734,0,0,1
185,Melatonin metabolism and effects WP3298,0.5098040713272052,1.4377125850340136,0.9686283760194752,['PER2'],0.7346434493273734,0,0,1
186,Nuclear receptors WP170,0.5098040713272052,1.4377125850340136,0.9686283760194752,['NR4A1'],0.7346434493273734,0,0,1
187,PDGFR-beta pathway WP3972,0.5098040713272052,1.4377125850340136,0.9686283760194752,['FOS'],0.7346434493273734,0,0,1
188,Prion disease pathway WP3995,0.5098040713272052,1.4377125850340136,0.9686283760194752,['EBF1'],0.7346434493273734,0,0,1
189,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5217212282906374,1.3880336617405582,0.9030850693567164,['PRKCH'],0.7346434493273734,0,0,1
190,miRNA regulation of prostate cancer signaling pathways WP3981,0.5217212282906374,1.3880336617405582,0.9030850693567164,['CCND1'],0.7346434493273734,0,0,1
191,Alzheimer's disease WP2059,0.5245018600964696,1.1500213219616204,0.7421160096399466,"['CASP8', 'CYCS']",0.7346434493273734,0,0,2
192,Retinoblastoma gene in cancer WP2446,0.5245018600964696,1.1500213219616204,0.7421160096399466,"['CCND1', 'RPA3']",0.7346434493273734,0,0,2
193,Neural Crest Cell Migration in Cancer WP4565,0.5333495051023289,1.3416666666666666,0.8433426032354093,['FOS'],0.7346434493273734,0,0,1
194,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5333495051023289,1.3416666666666666,0.8433426032354093,['ANGPT2'],0.7346434493273734,0,0,1
195,Development of ureteric collection system WP5053,0.5446958840259387,1.2982910906298004,0.7887477366389961,['CCND1'],0.7346434493273734,0,0,1
196,IL-2 signaling pathway WP49,0.5446958840259387,1.2982910906298004,0.7887477366389961,['FOS'],0.7346434493273734,0,0,1
197,Mitochondrial CIV Assembly WP4922,0.5446958840259387,1.2982910906298004,0.7887477366389961,['COX14'],0.7346434493273734,0,0,1
198,Prostaglandin Synthesis and Regulation WP98,0.5446958840259387,1.2982910906298004,0.7887477366389961,['HSD11B1'],0.7346434493273734,0,0,1
199,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5557671791544804,1.2576264880952381,0.7387371121505935,['CASP8'],0.7346434493273734,0,0,1
200,p38 MAPK Signaling Pathway WP400,0.5557671791544804,1.2576264880952381,0.7387371121505935,['DDIT3'],0.7346434493273734,0,0,1
201,Parkinson's disease pathway WP2371,0.5557671791544804,1.2576264880952381,0.7387371121505935,['CYCS'],0.7346434493273734,0,0,1
202,Glioblastoma signaling pathways WP2261,0.5608610161319513,1.072955223880597,0.6204708507506731,"['PRKCH', 'CCND1']",0.7346434493273734,0,0,2
203,Focal Adhesion WP306,0.5609919854877897,1.011955351577993,0.5849594346351663,"['SHC4', 'CCND1', 'CAV3', 'FN1']",0.7346434493273734,0,0,4
204,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5665700402561662,1.219426406926407,0.6928226850698889,['FOS'],0.7346434493273734,0,0,1
205,Bladder cancer WP2828,0.5665700402561662,1.219426406926407,0.6928226850698889,['CCND1'],0.7346434493273734,0,0,1
206,Vitamin D-sensitive calcium signaling in depression WP4698,0.5665700402561662,1.219426406926407,0.6928226850698889,['PVALB'],0.7346434493273734,0,0,1
207,DNA Replication WP466,0.5665700402561662,1.219426406926407,0.6928226850698889,['RPA3'],0.7346434493273734,0,0,1
208,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5665700402561662,1.219426406926407,0.6928226850698889,['IGFBP5'],0.7346434493273734,0,0,1
209,IL-5 signaling pathway WP127,0.5665700402561662,1.219426406926407,0.6928226850698889,['FOS'],0.7346434493273734,0,0,1
210,Senescence and Autophagy in Cancer WP615,0.574839339798296,1.0449311882147703,0.5785414985000218,"['IGFBP5', 'FN1']",0.7348182126666898,0,0,2
211,TNF-alpha signaling pathway WP231,0.574839339798296,1.0449311882147703,0.5785414985000218,"['CASP8', 'NFKBIE']",0.7348182126666898,0,0,2
212,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.574839339798296,1.0449311882147703,0.5785414985000218,"['SHC4', 'CCND1']",0.7348182126666898,0,0,2
213,Wnt signaling pathway and pluripotency WP399,0.5817061892559061,1.0314580941446614,0.558833462340292,"['PRKCH', 'CCND1']",0.7359277679759163,0,0,2
214,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5873962620728049,1.1495748299319728,0.6116377531870822,['CCND1'],0.7359277679759163,0,0,1
215,Pathways Regulating Hippo Signaling WP4540,0.5884912899096899,1.018326091063669,0.5399095208857368,"['PRKCH', 'PRKD3']",0.7359277679759163,0,0,2
216,Androgen receptor signaling pathway WP138,0.5951945552624616,1.0055223880597015,0.5217323278615915,"['CCND1', 'ETV5']",0.7359277679759163,0,0,2
217,G Protein Signaling Pathways WP35,0.5951945552624616,1.0055223880597015,0.5217323278615915,"['PRKCH', 'PRKD3']",0.7359277679759163,0,0,2
218,Pancreatic adenocarcinoma pathway WP4263,0.5951945552624616,1.0055223880597015,0.5217323278615915,"['CCND1', 'TGFBR2']",0.7359277679759163,0,0,2
219,Copper homeostasis WP3286,0.5974321363642124,1.1175595238095237,0.575671205775772,['CCND1'],0.7359277679759163,0,0,1
220,Proximal tubule transport WP4917,0.5974321363642124,1.1175595238095237,0.575671205775772,['SLC3A1'],0.7359277679759163,0,0,1
221,Integrated Cancer Pathway WP1971,0.6072246110734809,1.0872747747747749,0.5423941122232023,['CASP8'],0.741251664868979,0,0,1
222,PDGF Pathway WP2526,0.6072246110734809,1.0872747747747749,0.5423941122232023,['FOS'],0.741251664868979,0,0,1
223,Metabolic reprogramming in colon cancer WP4290,0.6167795722012159,1.0585839598997493,0.5115538985754343,['PGAM1'],0.7495393007467691,0,0,1
224,ErbB signaling pathway WP673,0.6211893098348388,0.9573560767590619,0.4558157977414859,"['SHC4', 'CCND1']",0.7515281382376844,0,0,2
225,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.6274838433475071,0.9460228270412643,0.4408819769931084,"['SLC25A5', 'COX7A1']",0.7524253165804178,0,0,2
226,Osteoblast differentiation WP4787,0.6274838433475071,0.9460228270412643,0.4408819769931084,"['PRKCH', 'FGF1']",0.7524253165804178,0,0,2
227,"GPCRs, Other WP117",0.6351997916808643,1.0055059523809524,0.4563143846250546,['GNRHR'],0.7577211011609473,0,0,1
228,Male infertility WP4673,0.6398291143804402,0.9241379310344827,0.4126776255609044,"['TEX15', 'ETV5']",0.7577211011609473,0,0,2
229,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.6440761259976872,0.9809088269454123,0.43153941258543643,['MSMO1'],0.7577211011609473,0,0,1
230,Eukaryotic Transcription Initiation WP405,0.6440761259976872,0.9809088269454123,0.43153941258543643,['POLR2K'],0.7577211011609473,0,0,1
231,ESC Pluripotency Pathways WP3931,0.6458803482220621,0.9135685210312076,0.3993582676552992,"['FOS', 'FGF1']",0.7577211011609473,0,0,2
232,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6527371052320798,0.9574829931972789,0.40844388623937156,['ADCY10'],0.7624644634391967,0,0,1
233,Nucleotide Excision Repair WP4753,0.6611879391451123,0.9351467331118494,0.38688624505060204,['RPA3'],0.7657347500355789,0,0,1
234,RANKL/RANK signaling pathway WP2018,0.6611879391451123,0.9351467331118494,0.38688624505060204,['FOS'],0.7657347500355789,0,0,1
235,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6694337117261836,0.9138257575757576,0.3667394136377937,['FOS'],0.77198525905445,0,0,1
236,Modulators of TCR signaling and T cell activation WP5072,0.6774793843827391,0.893452380952381,0.34788905334855547,['PTPN6'],0.7779530218971284,0,0,1
237,Wnt Signaling Pathway WP363,0.6853297988619284,0.8739648033126294,0.33023205674607264,['CCND1'],0.7836471539729223,0,0,1
238,Glucocorticoid Receptor Pathway WP2880,0.6929896800219372,0.855306484295846,0.31367524686089754,['B3GNT5'],0.7857749091462132,0,0,1
239,Interferon type I signaling pathways WP585,0.6929896800219372,0.855306484295846,0.31367524686089754,['PTPN6'],0.7857749091462132,0,0,1
240,Selenium Micronutrient Network WP15,0.7077561747518821,0.8202745383867833,0.283532512787359,['SELENOH'],0.7925699312304134,0,0,1
241,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7077561747518821,0.8202745383867833,0.283532512787359,['PRKCH'],0.7925699312304134,0,0,1
242,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7077561747518821,0.8202745383867833,0.283532512787359,['CASP8'],0.7925699312304134,0,0,1
243,Notch Signaling Pathway Netpath WP61,0.7148716790397673,0.8038095238095239,0.2698004529478348,['CCND1'],0.7972437243612219,0,0,1
244,Mesodermal commitment pathway WP2857,0.7272204113983005,0.7796551224460223,0.24834016871267955,"['CCND1', 'TRIM5']",0.8076915224956535,0,0,2
245,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7351983378423487,0.7581424079065588,0.23321595312911933,['FN1'],0.813219385939904,0,0,1
246,AMP-activated protein kinase (AMPK) signaling WP1403,0.7600705461072286,0.7047305764411027,0.1933386237160518,['LEPR'],0.8373134877847924,0,0,1
247,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7771834213700787,0.669345238095238,0.16872780660952355,['CCND1'],0.8526992193979406,0,0,1
248,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.782612826207895,0.6583235753317721,0.1613664183882874,['CASP8'],0.8551938544449175,0,0,1
249,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8021265285657477,0.721370018667316,0.15905409436552395,"['ANGPT2', 'LPAR6', 'FN1', 'FGF1']",0.8704984468089214,0,0,4
250,T-cell receptor (TCR) signaling pathway WP69,0.803042847609706,0.6176282051282052,0.13547502178684695,['FOS'],0.8704984468089214,0,0,1
251,16p11.2 proximal deletion syndrome WP4949,0.8078438620358545,0.6082251082251082,0.1297870143984692,['CASP8'],0.8717374121799129,0,0,1
252,Regulation of Actin Cytoskeleton WP51,0.8106192910307677,0.6519111758281761,0.13687316259525967,"['FN1', 'FGF1']",0.8717374121799129,0,0,2
253,Calcium Regulation in the Cardiac Cell WP536,0.8141242208584575,0.646605681271064,0.13296949186917784,"['PRKCH', 'PLN']",0.8717863485916123,0,0,2
254,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8170986440674152,0.5902485994397759,0.11922753265860109,['CCND1'],0.8717863485916123,0,0,1
255,Pyrimidine metabolism WP4022,0.8498807825730131,0.5278038847117794,0.08585215507423002,['POLR2K'],0.9032066355972022,0,0,1
256,B Cell Receptor Signaling Pathway WP23,0.8571160950069264,0.5141941391941391,0.07927943079295906,['PTPN6'],0.9073377411987386,0,0,1
257,Integrin-mediated Cell Adhesion WP185,0.8705601616810762,0.4889663182346109,0.06777973383333971,['CAV3'],0.9156804829266967,0,0,1
258,Ciliary landscape WP4352,0.8717548509043828,0.6027893960822075,0.08273105365432412,"['DOCK5', 'CDH23', 'COPS7A']",0.9156804829266967,0,0,3
259,Wnt signaling WP428,0.88560522849982,0.4606937602627258,0.05596691786864245,['CCND1'],0.9189156231434958,0,0,1
260,7q11.23 copy number variation syndrome WP4932,0.8883981301239702,0.45542478354978355,0.053892824623453954,['CLDN5'],0.9189156231434958,0,0,1
261,DNA damage response (only ATM dependent) WP710,0.8883981301239702,0.45542478354978355,0.053892824623453954,['CCND1'],0.9189156231434958,0,0,1
262,Hippo-Merlin Signaling Dysregulation WP4541,0.8883981301239702,0.45542478354978355,0.053892824623453954,['CCND1'],0.9189156231434958,0,0,1
263,Thermogenesis WP4321,0.8989061269373072,0.43549430641821946,0.04641353271513353,['ADCY10'],0.9234357969863446,0,0,1
264,Ciliopathies WP4803,0.8995832118243356,0.512743972445465,0.05426047503003166,"['EVC', 'CCDC65']",0.9234357969863446,0,0,2
265,Cell cycle WP179,0.9106645255943101,0.41289273441335295,0.03863879031305965,['CCND1'],0.9277822798348047,0,0,1
266,Ebola Virus Pathway on Host WP4217,0.9106645255943101,0.41289273441335295,0.03863879031305965,['CAV3'],0.9277822798348047,0,0,1
267,Genes related to primary cilium development (based on CRISPR) WP4536,0.917054269520461,0.40041666666666664,0.034671529348208094,['EVC'],0.9307929102623406,0,0,1
268,Chemokine signaling pathway WP3929,0.9336161981754412,0.367108999563128,0.02521666135355699,['SHC4'],0.9440671257669573,0,0,1
269,DNA Repair Pathways Full Network WP4946,0.9427811582989003,0.34780020703933745,0.02049276832819081,['RPA3'],0.9497906836394125,0,0,1
270,Ras signaling WP4223,0.9741212184092924,0.2714407191448008,0.007117047770590514,['SHC4'],0.9753747653106518,0,0,1
271,EGF/EGFR signaling pathway WP437,0.9753747653106518,0.2677572706935123,0.0066761278259038935,['FOS'],0.9753747653106518,0,0,1
